HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Supplemental Data All Versions of this Article: jnumed.107.047423v1 49/5/830    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeong, J. M. Articles by Lee, M. C. Search for Related Content PubMed PubMed Citation Articles by Jeong, J. M. Articles by Lee, M. C.

Preparation of a Promising Angiogenesis PET Imaging Agent: ⁶⁸Ga-Labeled c(RGDyK)–Isothiocyanatobenzyl-1,4,7-Triazacyclononane-1,4,7-Triacetic Acid and Feasibility Studies in Mice

¹ Department of Nuclear Medicine, Cancer Research Institute College of Medicine, Seoul National University, Seoul, Korea; and ² Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

Correspondence: For correspondence or reprints contact: Jae Min Jeong, Department of Nuclear Medicine, Seoul National University Hospital, 28 Yungun-dong, Jongro-gu, Seoul 110-744, Korea. E-mail: jmjng{at}snu.ac.kr

Arg-Gly-Asp (RGD) derivatives have been labeled with various radioisotopes for the imaging of angiogenesis in ischemic tissue, in which _vβ₃ integrin plays an important role. In this study, cyclic Arg-Gly-Asp-D-Tyr-Lys [c(RGDyK)] was conjugated with 2-(p-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (SCN-Bz-NOTA) and then labeled with ⁶⁸Ga. The labeled RGD so produced was subjected to an in vitro binding assay and in vivo biodistribution and PET studies. Methods: A mixture of SCN-Bz-NOTA (660 nmol) and c(RGDyK) (600 nmol) in 0.1 M sodium carbonate buffer (pH 9.5) was allowed to react for 20 h at room temperature in the dark for thiourea bond formation. The conjugate obtained was purified by semipreparative high-performance liquid chromatography (HPLC). The purified c(RGDyK)–SCN-Bz-NOTA (NOTA-RGD) was then labeled with ⁶⁸Ga from a ⁶⁸Ge/⁶⁸Ga generator and purified by semipreparative HPLC. A competitive binding assay for c(RGDyK) and NOTA-RGD was performed with ¹²⁵I-c(RGDyK) as a radioligand and _vβ₃ integrin–coated plates as a solid phase. ⁶⁸Ga-NOTA-RGD (0.222 MBq/100 µL) was injected, through a tail vein, into mice with hind limb ischemia and into mice bearing human colon cancer SNU-C4 xenografts. Biodistribution and imaging studies were performed at 1 and 2 h after injection. Results: The labeling of NOTA-RGD with ⁶⁸Ga was straightforward. The K_i values of c(RGDyK) and NOTA-RGD were 1.3 and 1.9 nM, respectively. In the biodistribution study, the mean ± SD uptake of ⁶⁸Ga-NOTA-RGD by ischemic muscles was 1.6 ± 0.2 percentage injected dose per gram (%ID/g); this uptake was significantly blocked by cold c(RGDyK) to 0.6 ± 0.3 %ID/g (P < 0.01). Tumor uptake was 5.1 ± 1.0 %ID/g, and the tumor-to-blood ratio was 10.3 ± 4.8. Small-animal PET revealed rapid excretion through the urine and high levels of tumor and kidney uptake. Conclusion: Stable ⁶⁸Ga-NOTA-RGD was obtained in a straightforward manner at a high yield and showed a high affinity for _vβ₃ integrin, specific uptake by angiogenic muscles, a high level of uptake by tumors, and rapid renal excretion. ⁶⁸Ga-NOTA-RGD was found to be a promising radioligand for the imaging of angiogenesis.

Key Words: integrin • NOTA • gallium • peptide • ischemia • DOTA

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  

This article has been cited by other articles:

				D. W. Hwang, H. Y. Ko, J. H. Lee, H. Kang, S. H. Ryu, I. C. Song, D. S. Lee, and S. Kim A Nucleolin-Targeted Multimodal Nanoparticle Imaging Probe for Tracking Cancer Cells Using an Aptamer J. Nucl. Med., January 1, 2010; 51(1): 98 - 105. [Abstract] [Full Text] [PDF]